0000950170-23-026422.txt : 20230605 0000950170-23-026422.hdr.sgml : 20230605 20230605170324 ACCESSION NUMBER: 0000950170-23-026422 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230601 FILED AS OF DATE: 20230605 DATE AS OF CHANGE: 20230605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Atkinson Edward Morrow III CENTRAL INDEX KEY: 0001914164 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39122 FILM NUMBER: 23993592 MAIL ADDRESS: STREET 1: C/O 89BIO, INC. STREET 2: 142 SANSOME STREET, SECOND FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 89bio, Inc. CENTRAL INDEX KEY: 0001785173 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831114349 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 142 SANSOME STREET STREET 2: SECOND FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: (415) 432-9270 MAIL ADDRESS: STREET 1: 142 SANSOME STREET STREET 2: SECOND FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 4 1 ownership.xml 4 X0407 4 2023-06-01 0001785173 89bio, Inc. ETNB 0001914164 Atkinson Edward Morrow III C/O 89BIO, INC. 142 SANSOME STREET, 2ND FLOOR SAN FRANCISCO CA 94104 true false false false false Common Stock 2023-06-01 4 M false 6250 2.61 A 6250 D Common Stock 2023-06-01 4 S false 6250 17.91 D 0 D Stock Option (Right to Buy) 2.61 2023-06-01 4 M false 6250 0.00 D 2032-05-25 Common Stock 6250 0.00 D This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on January 30, 2023 in multiple trades at prices ranging from $17.53 to $18.18. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. This option represents a right to purchase a total of 6,250 shares of the Issuer's Common Stock, which vested in full on May 16, 2023. /s/ Ryan A. Murr, as attorney-in-fact for Edward Morrow Atkinson III 2023-06-05